Hints and tips:
Related Special Reports
...“Private equity continues to have a love affair with pharma-adjacent suppliers,” said Robert Darwin, a partner at law firm Sidley Austin and specialist in life sciences transactions....
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...The partnership strengthens Sanofi, one of the world’s largest vaccine makers by sales, in the post-pandemic Covid jab market, where pharmaceutical groups are increasingly focused on combined shots against...
...Pfizer is “trying to leverage some of that brand equity that they got the world spinning again”, said Markus Saba, a marketing professor at the University of North Carolina Center for the Business of Health...
...The move has big implications for the nascent category of psychedelic-based treatments for mental health problems — as a number of other biotechs conduct late-stage trials into psychedelic-based mental health...
...The announcement comes after the pharmaceutical group requested in March that the European Union marketing authorisation for Vaxzevria be withdrawn, a request that was granted on Tuesday....
...While UK business groups say employers are increasingly concerned about the rising cost of medical cover for their staff as NHS waiting lists push people towards private healthcare, long Covid does not loom...
...A study by Boston Consulting Group published this week suggests that drugs discovered by AI have a higher success rate in early stage trials than those discovered by other methods....
...“It is true that the science isn’t there yet,” Meg Jones-Monteiro, senior director for health equity at ICCR, told me, arguing that companies should exercise caution in the absence of a clear scientific...
...Leqembi slowed cognitive decline by 27 per cent compared with the placebo group in a phase 3 trial....
...Deaths from the condition have fallen in most high-income states over the past 30 years, partly reflecting public health campaigns and increased testing....
...The positive data will also be a boon to Eli Lilly’s efforts to push for more widescale coverage of the drugs by private insurers and US federal health insurance programme Medicare, which were both initially...
...Nearly seven men out of every 1,000 in the group invited for screening had died from prostate cancer, compared with nearly eight men out of every 1,000 in the group which had not....
...According to a poll published last month by Opinium on behalf of the campaign group Dignity in Dying, 75 per cent of people living in the UK support assisted dying....
...The Group for Equity, made up of Asian, African and Latin American countries, wants firm rules in place....
...“It’s a new paradigm in how to understand these conditions and develop drugs,” said Sergiu Pașca, project leader and Stanford’s professor of psychiatry and behavioural sciences....
...World Health Organization member states started the last round of talks on the accord on Monday....
...Orchard’s MLD treatment was given list prices of up to $3.9mn when it was approved across Europe in 2020 under the brand name Libmeldy, but national health systems negotiated steep discounts....
...The risks faced by the group of people Nyborg wants to target are serious....
...The results will renew attention on the possible effectiveness of lixisenatide, which is made by French pharmaceutical group Sanofi, and other so-called GLP-1 drugs against neurodegenerative conditions....
...The writer is a science commentator Four years ago this week, the World Health Organization declared the rapid spread of a new coronavirus to be a pandemic....
...AMR, largely caused by excessive use of antibiotics, is already linked to 5mn deaths a year, according to the World Health Organization....
...A study published last month pointed to changes in the “complement system”, a group of proteins that help the body fight infections....
...Companies and investors are also realising the risks of deforestation, says Tim Steinweg, head of stewardship for nature at the PRI, a group focused on responsible investment — with many considering it as...
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
International Edition